3Bataller R, Gines P, Guevara M, et al. Hepatorenal syndrome. Seminars in liver disease, 1997,17:233.
4Seubert John M, Darmon Alison J, El Kadi Ayman O S, et al. Apoptosis in murine hepatoma hepa 1c1c7 wild-type, C12, and C4 cells mediated by bilirubin [J]. Mol-Pharmacol (Molecular), 2002, 62(2):257-264.
5Welsh FK, Ramsden CW, MacLennan K, et al. Increased intestinal permeability and altered mucosal immunity in cholestatic jaundice [J]. Ann Surg, 1998, 227(2):205-212.
6Minetoshi Tomioka, Hisae Iinuma, Kota Okinaga. Impaired Kupffer Cell Function and Effect of Immunotherapy in Obstructive Jaundice [J]. Journal of Surgical Research, 2000, 92:276-282.
7Toshinori Kamisako, Shozo Miyawaki, Esteban C. Gabazza, et al. Polyethylene glycol-modified bilirubin oxidase improves hepatic energy charge and urinary prostaglandin levels in rats with obstructive jaundice[J]. Journal of Hepatology, 1998, 29:424-429.
8Wei Tu, Hiroaki Kitade, Sohei Satoi, et al. Increased Nitric Oxide Production in Hepatocytes Is Involved in Liver Dysfunction Following Obstructive Jaundice [J]. Journal of Surgical Research, 2002,106:31-36.
9Yuh Fujiwara, Mitsuo Shimada, Yoichi Yamashita, et al. Cytokine Characteristics of Jaundice in Mouse Liver [J]. CYTOKINE, 2001, 13(3):188-191.
10Yoshiaki Shimizu, Masaru Miyazaki, Hiroshi Ito, et al. Enhanced endothelial cell injury by activated neutrophils in patients with obstructive jaundice [J]. Journal of Hepatology, 1997, 27:803-809.
